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Background. Little is known on the prevalence of peripheral artery disease (PAD) in developing countries. Study design. Population-
based study in Atahualpa. In Phase I, the Edinburgh claudication questionnaire (ECQ) was used for detection of suspected
symptomatic PAD; persons with a negative ECQ but a pulse pressure ≥65mmHg were suspected of asymptomatic PAD. In Phase
II, the ankle-brachial index will be used to test reliability of screening instruments and to determine PAD prevalence. In Phase
III, participants will be followed up to estimate the relevance of PAD as a predictor of vascular outcomes. Results. During Phase
I, 665 Atahualpa residents aged ≥40 years were enrolled (mean age: 59.5 ± 12.6 years, 58% women). A poor cardiovascular health
status was noticed in 464 (70%) persons of which 27 (4%) had a stroke and 14 (2%) had ischemic heart disease. Forty-four subjects
(7%) had suspected symptomatic PAD and 170 (26%) had suspected asymptomatic PAD. Individuals with suspected PAD were
older, more often women, and had a worse cardiovascular profile than those with nonsuspected PAD. Conclusions. Prevalence of
suspected PAD in this underserved population is high. Subsequent phases of this study will determine whether prompt detection
of PAD is useful to reduce the incidence of catastrophic vascular diseases in the region.
1. Introduction
Underserved populations of LatinAmerica are going through
a process of epidemiologic transition due to increases in
life expectancy and changes in dietary habits and lifestyles
[1]. As a consequence, the incidence and prevalence rates of
cardiovascular diseases are increasing to the point that these
conditions are considered to be the next health epidemics
of the region [2]. Epidemiologic surveys assessing specific
risk factors are mandatory to define and to respond to the
potential burden of ischemic heart disease and stroke in
these regions. Such surveys may prove to be cost-effective for
developing strategies directed to improve the cardiovascular
health of other populations or ethnic groups [3].
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Peripheral artery disease (PAD) is the third most com-
mon vascular disease, affecting more than 10% of individuals
greater than 70 years of age worldwide [4]. This condition
is an important marker of systemic atherosclerosis and has
been independently associated with an increased risk of
ischemic heart disease and stroke [5–7]. Despite this, there
is controversy regarding the role of routine screening and
prompt detection of PAD [8]. Prior conflicting results have
been, at least in part, due to a lack of standardization of
diagnostic methods used for PAD diagnosis in population-
based surveys, the fact that only either asymptomatic or
symptomatic individuals have been screened, and differences
in the age, race/ethnicity, and cardiovascular risk status
across studied populations [9–11]. Most cohort studies have
been conducted in the developed world; little longitudinal
information is available from the few cross-sectional sur-
veys assessing PAD prevalence in low- and middle-income
countries [12–15]. Thus, we performed a population-based
cohort study to determine the prevalence, clinical correlates,
evolution, and outcome of PAD in a rural Ecuadorian
community, which may be used as a template for other
community-based studies attempting to reduce the burden of
noncommunicable diseases in rural areas of low- andmiddle-
income countries.
2. Methods
2.1. Population Studied. Atahualpa is located in rural coastal
Ecuador (2∘18󸀠S, 80∘46󸀠W) and was selected for the study
as a village representative of the region. More than 95% of
the population belongs to the Native/Mestizo ethnic group
(Amerindians). All inhabitants speak Spanish and most men
belong to the blue-collar class (artisan carpenters) and most
women are homemakers, with a rather homogeneous family
income rate that fluctuates from US$ 5,000 to $ 12,000 per
year. Atahualpa is relatively isolated and closed; inhabitants
do not migrate and many of them have never visited large
urban centers. People mobilize within the village mainly
by walking or bicycle riding, as very few own a motor
vehicle.There are no fast-food restaurants; most people eat at
home. The diet is rich in fish and carbohydrates but poor in
polyunsaturated fats and dairy products. The village has only
one health center of the Minister of Health staffed by general
physicians, nurses, dentists, and obstetricians.
2.2. The Atahualpa Project. The methodology and opera-
tional definitions of the Atahualpa Project have been detailed
elsewhere [16–18]. In brief, this multistep, population-based
cohort study was designed to reduce the burden of car-
diovascular and neurological diseases in the region, by
assessing and modifying risk factors through the implemen-
tation of intervention strategies directed at informing people
about their health status and the best ways to improve it
according to specific situations. The main protocols of this
project have been registered at http://www.clinicaltrials.gov/
(NCT01627600, NCT01831908, and NCT01877616) and the
informed consent forms for all substudies of the Atahualpa
Project have been approved by the IRB of Hospital-Cl´ınica
Kennedy, Guayaquil-Ecuador (FWA 00006867).
2.3. Study Design. This substudy of the Atahualpa Project
focused on the evaluation of prevalence, incidence, mortality,
and clinical correlates of PAD. It has been divided into three
main phases. In Phase I, trained field personnel (including
rural doctors) screened all Atahualpa residents aged ≥40
years to identify those with suspected PAD. Residents were
defined as persons who had been living in the village for
at least six months before the start of the survey (15 June,
2013). Persons declining to sign the informed consent were
excluded. At this time, cardiovascular risk factors and history
of vascular events (stroke and ischemic heart disease) were
assessed. During Phase II, the ankle-brachial index (ABI) will
be used as the gold standard for diagnosis of PAD in order
to test the reliability of the screening instruments as well as
to determine the actual prevalence of PAD and its clinical
correlates. In Phase III, all participants will be followed up on
a yearly basis to estimate the relevance of PAD as a predictor
of vascular outcomes and death.
2.4. Phase I (Basal Survey)
2.4.1. Detection of Persons with Suspected PAD. We used the
Edinburgh claudication questionnaire (ECQ) for detection
of cases with suspected symptomatic PAD [19]. This reliable
instrument consists of six questions directed not only to
detect suspected PAD cases but also to grossly assess their
severity.TheECQwas independently translated from its orig-
inal English version to Spanish by bilingual physicians from
our group (O.H.D., R.M.M.).Then, the Spanish version of the
ECQ was culturally adapted—including vernacular Spanish
words used by local people—with the aid of Atahualpa’s
community leaders and rural doctors working in the village
and tested in a random sample of the population before
the study (Table 1). In addition, the pulse pressure was
recorded due to its relevance in the evaluation of patients with
suspected PAD. It was calculated by subtracting the diastolic
pressure from the systolic pressure and a value ≥65mmHg
was considered as suggestive of asymptomatic PAD [20].
On the basis of results from the ECQ and pulse pressure
determinations, persons were classified into the following
three groups: (1) suspected symptomatic PAD, (2) suspected
asymptomatic PAD, and (3) nonsuspected PAD (Table 2).
2.4.2. Identification of Patients with Stroke and Ischemic
Heart Disease. To recognize persons with a history of stroke
and ischemic heart disease, all Atahualpa residents were
screened—during the survey—by rural doctors with the use
of validated field questionnaires. The field instrument for
the detection of stroke cases was that used for assessment
of stroke prevalence in previous surveys performed by our
group in the same village [21, 22]. For the detection of
cases of ischemic heart disease, we used a validated Spanish
translation of the Rose questionnaire [23], and we also asked
each person if they have ever had a diagnosis of myocar-
dial infarction. Then, certified neurologists and cardiologists
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Table 1: Culturally adapted Spanish translation of the Edinburgh claudication questionnaire [with original English version] used in Atahualpa
residents.
(1) Usted siente dolor o una sensacio´n desagradable en una o ambas piernas cuando camina? [Do you get a pain or discomfort in your









No puedo caminar [I am unable to walk]
Si usted contesto´ que “si” a la pregunta 1, por favor responda las siguientes preguntas. En caso contrario, no hay necesidad de
seguir adelante. [If you answered “yes” to question (1), please answer the following questions. Otherwise you need not continue.]























(5) Que sucede con este dolor si usted deja de caminar y se queda parado? [What happens to it if you stand still?]
◻
1
Suele persistir por ma´s de 10 minutos [Usually continues more than 10 minutes]
◻
2
Suele desaparecer en 10 minutos o menos [Usually disappears in 10 minutes or less]
(6) Sen˜ale con una “x” en este dibujo en que parte (de las piernas) siente usted el dolor o la sensacio´n desagradable [Where do you get
this pain or discomfort? Mark the place(s) with “x” on the diagram below]
Table 2: Operational categories of PAD suspicion used in the
Atahualpa Project.
Suspected Symptomatic PAD
(i) Positive Edinburgh claudication questionnaire and
increased pulse pressure∗
(ii) Positive Edinburgh claudication questionnaire and normal
pulse pressure
Suspected Asymptomatic PAD
Negative Edinburgh claudication questionnaire and
increased pulse pressure∗
Nonsuspected PAD
Negative Edinburgh claudication questionnaire and normal
pulse pressure
∗Defined as ≥65mmHg.
moved to Atahualpa in order to evaluate all suspected cases
and a random sample of negative individuals matched by
age and sex for each positive case. Stroke was diagnosed,
according to the World Health Organization definition, in
patients who had experienced a rapidly developing event
characterized by clinical signs of focal or global disturbance of
cerebral function, lasting ≥24 hours, with no apparent cause
other than a vascular cause [24]. Patients were considered to
have ischemic heart disease on the basis of clinical judgment
or ECG findings [25].
2.4.3. Assessment of Risk Factors. During the survey, demo-
graphic characteristics, cardiovascular risk factor, and other
PAD correlates of all enrolled persons, such as edentulism,
were recorded. Relevant demographic data included age,
sex, educational level, and alcohol intake (dichotomized in
<50 and ≥50 g per day). Cardiovascular risk factors were
assessed in the field by determining the cardiovascular health
(CVH) status of participants. For this, we used the seven
CVH metrics proposed by the American Heart Association
[26].These included smoking status, bodymass index (BMI),
physical activity, diet, blood pressure (BP), fasting glucose,
and total cholesterol levels. Smoking status and physical
activity were based on a self-report; BMI (kg/m2) was
calculated after obtaining the person’s height and weight; diet
was assessed by direct interviews with the aid of a validated
food frequency questionnaire [27]; BP was measured with
a Microlife BP A200 AFIB© digital sphygmomanometer
(Microlife Corporation, Taipei, Taiwan), using a well-defined
protocol described elsewhere [28]; and fasting glucose and
total cholesterol levels weremeasured by obtaining a capillary
blood sample, using Accu-chek Active and Accutrend Plus
devices (Roche Diagnostics, Mannheim, Germany), respec-
tively. Each CVHmetric was classified as ideal, intermediate,
or poor, and the CVH status of a person was classified as poor
if at least one CVH metric was in the poor range (Table 3).
Edentulism, which was used as a proxy of periodontitis
and chronic inflammation, was also investigated in the entire
population, as some studies have shown an association
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Table 3: Cardiovascular health metrics and status according to the American Heart Association.
Cardiovascular Health Metrics
(1) Smoking: ideal (never or quit >1 year), intermediate (quit ≤1 year), and poor (current smoker).
(2) Body mass index: ideal (<25 kg/m2), intermediate (25 to <30 kg/m2), and poor (≥30 kg/m2).
(3) Physical activity: ideal (≥150 minutes/week moderate intensity or ≥75 minutes/week vigorous intensity or equivalent
combination), intermediate (1–149 minutes/week moderate intensity or 1–74 minutes/week vigorous intensity or equivalent
combination), and poor (no moderate and vigorous activity).
(4) Diet: ideal (4-5 healthy components), intermediate (2-3 healthy components), and poor (0-1 healthy component); based on 5
health dietary components (≥4.5 cups fruits and vegetables/day, ≥two 3.5-oz servings fish/week, ≥three 1-oz equivalent servings
fiber-rich whole grains/day, <1,500mg sodium/day, and ≤450 kcal sugar-sweetened beverages/week).
(5) Total cholesterol: ideal (untreated and <200mg/dL), intermediate (treated to <200mg/dL or 200–239mg/dL), and poor
(≥240mg/dL).
(6) Blood pressure: ideal (untreated and <120/<80mmHg), intermediate (treated to <120/<80mmHg or 120–139/80–89mmHg), and
poor (≥140/90mmHg).
(7) Fasting glucose: ideal (untreated and <100mg/dL), intermediate (treated to <100mg/dL or 100–125/mg/dL), and poor
(≥126mg/dL).
Cardiovascular Health Status
(1) Ideal CVH status: all seven CVHmetrics in the ideal range.
(2) Intermediate CVH status: CVH metrics in the ideal and intermediate range, but no poor metrics.
(3) Poor CVH status: at least one CVHmetric in the poor range.
between this covariate and PAD [29, 30]. For this, a rural
dentist performed an oral exam during the survey with
emphasis on the number of remaining teeth. Individuals were
classified in three groups according to whether they had <10,
10–19, or ≥20 teeth.
2.5. Phase II (Confirmation of Suspected Cases of PAD). For
this phase of the study, trained medical students—under
the supervision of a certified cardiologist—will perform the
ankle-brachial index (ABI) in all persons whowere suspected
to have symptomatic (ECQ positive) and asymptomatic PAD
(pulse pressure ≥ 65mm/Hg with a negative ECQ) during
Phase I and in a random sample of a similar number of
negative individuals that will be matched by age and sex with
suspected cases. Those with amputations, fractures, or leg
ulcers preventing ABI measurements will be excluded.
A manual sphygmomanometer (Welch Allyn Tycos©
7670-01) and a portable vascular Doppler (Nicolet n800©)
with an 8MHz probe will be used for all BP determinations,
which will be carried out at the community center of the
Atahualpa Project under comfortable temperature levels with
the patient resting in the supine position for at least 10
minutes before the test. According to the recommendations
of the American Heart Association regarding cuff size and
positions, BP will be measured in both arms and legs with
the aid of both devices (the sphygmomanometer and the
Doppler) following a counterclockwise sequence: right arm,
right posterior tibial, right dorsalis pedis, left posterior tibial,
left dorsalis pedis, and left arm [31]. ABIs will be reported
separately for each leg and calculated by dividing the higher
of the posterior tibial or dorsalis pedis BP by the higher right
or left arm systolic BP. An ABI ≤ 0.9 will be considered as a
diagnostic of lower-limb PAD. Persons with an ABI ≥ 1.4 will
not be diagnosed as PAD and will be excluded from the main
analysis but will be considered at an increased risk for
vascular events and death as these high indices are suggestive
of a rigid and incompressible wall in an artery affected by
atherosclerosis [32]. Those persons will be followed up and
evaluated in a separate analysis.
2.6. Phase III (Cohort Study). All participants in the Phase
I survey will be followed up yearly for at least five years
to evaluate PAD progression (defined as a decrease ≥0.15
in the ABI), the rate of transformation of asymptomatic to
symptomatic PAD, and the quality of life of symptomatic
patients. The latter will be evaluated by the use of the
walking impairment questionnaire [33] and the vascular
quality of life questionnaire-6 (VascQoL-6), which is an
abridged, yet equally reliable, version of the Vasc-QoL-25
[34]. In addition, we will assess the prospective incidence
of stroke and ischemic heart disease as well as the mortality
rate among persons with and without PAD. For this, we will
review death certificates and medical records from the single
Health Center of Atahualpa and conduct yearly door-to-door
surveys using the same approach as described for Phase I.
By the end of the study, it will be possible to estimate the
relevance of PAD as a predictor of vascular outcomes and
death.
2.7. Statistical Analyses. All analyses are carried out by using
STATA version 13 (College Station, TX, USA). Descriptive
statistics are presented as means ± standard deviations for
continuous variables and as percentages with 95% CI for
categorical variables. A 𝑃 value of less than 0.05 is considered
significant. For Phase I results, differences on traditional
and nontraditional cardiovascular risk factors across per-
sons with and without suspected PAD (symptomatic and
asymptomatic) were presented. During Phase II, reliability
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≥65 (𝑛 = 205) <65 (𝑛 = 460)
Age (mean ± SD) 59.5 ± 12.6 68.4 ± 11.7 55.6 ± 10.9 0.0001
Women, 𝑛 (%) 384 (58%) 134 (65%) 250 (54%) 0.008
Up to primary school, 𝑛 (%) 426 (64%) 157 (77%) 269 (58%) 0.0001
Alcohol intake ≥50 g/day, 𝑛 (%) 114 (17%) 23 (11%) 91 (20%) 0.007
Current smokers, 𝑛 (%) 12 (2%) 3 (1.5%) 9 (2%) 0.659
Body mass index, kg/m2 (mean ± SD) 27 ± 5 27 ± 5 27 ± 5 ⋅ ⋅ ⋅
Fasting glucose, mg/dL (mean ± SD) 140 ± 86 142 ± 92 135 ± 83 0.332
Total cholesterol, mg/dL (mean ± SD) 199 ± 33 198 ± 32 199 ± 33 0.716
Poor CVH status, 𝑛 (%) 464 (70%) 187 (91%) 277 (60%) 0.0001
Severe edentulism, 𝑛 (%) 192 (29%) 85 (41%) 107 (23%) 0.0001
Stroke or ischemic heart disease, 𝑛 (%) 41 (6%) 25 (12%) 16 (3%) 0.0001
of the ECQ and pulse pressure calculation for detection of
patients with symptomatic and asymptomatic PAD will be
assessed by calculating their sensitivity and specificity as
well as their positive and negative predictive values (using
numbers of true and false positive suspected cases and those
of true and false negative controls). Using generalized linear
analysis, we will evaluate the association between confirmed
PAD and all the other variables, after adjusting for age, sex,
education, and alcohol intake. Univariate and multivariate
analyses will be performed with PAD as the dependent
variable; the output of the model will be the odds ratio of
a given relationship. To compare the incidence of vascular
events and death between thosewith andwithout PAD (Phase
III) we will use time-to-event univariate methods such as
Kaplan-Meir curves and the log rank test. Cox proportional
regression models (hazard ratios and 95% C.I.) and Poisson
regressionmodels (adjusted incidence rates and 95%C.I.) will
be used to evaluate progression of PAD and the association
between PAD and the incidence of vascular events and death,
after adjusting for demographics, cardiovascular risk factors,
and other confounders.
3. Results (Phase I)
The door-to-door census identified 688 Atahualpa residents
aged ≥40 years, 23 (3.3%) of whom declined to participate.
Mean age of the 665 enrolled persons was 59.5 ± 12.6 years;
384 (58%) were women and 426 (64%) had up to primary
school education. Alcohol consumption ≥ 50 g per day was
admitted by 114 (17%) persons.
Mean values for the quantitative measures obtained were
as follows: height 149 ± 9 cm, weight 60 ± 12 kg, BMI 27 ±
5 kg/m2, systolic BP 138 ± 25mmHg, diastolic BP 77 ±
12mmHg, pulse pressure 61± 21mmHg, fasting glucose 140 ±
86mg/dL, and total cholesterol 199 ± 33mg/dL. In the study
cohort, 75 persons (11%) were on antihypertensive, 68 (10%)
on hypoglycemic, and 16 (2.4%) on hypocholesterolemic
drugs (15% were taking combinations of these drugs).
Overall, 10 persons (1.5%) had all seven CVH metrics
in the ideal range (ideal CVH status); 191 (29%) had a
combination of ideal and intermediate but not poor CVH
metrics (intermediate CVH status); and the remaining 464
(70%) had one or more CVHmetrics in the poor range (poor
CVH status). Most of these individuals have only one or two
CVH metrics in the poor range (mean ± SD1.1 ± 1). The
individual CVHmetric that was most often in the poor range
was BP (36%), followed by fasting glucose levels (30%) and
BMI (25%). On the oral exam, 192 (29%) had <10 remaining
teeth (severe edentulism). A total of 41 persons (6%) had a
history of a vascular event, including stroke in 27 cases and
ischemic heart disease in 14 (there were no individuals with
history of both stroke and ischemic heart disease).
A total of 205 persons (31%) had a pulse pressure ≥
65mmHg. Persons with a high pulse pressure were older,
more often women, and less educated than those with a pulse
pressure < 65mmHg. In contrast, alcohol intake ≥50 g per
day was most common among persons with normal pulse
pressure values.Therewere no significant differences inmean
values of BMI, fasting glucose, and total cholesterol levels
across groups of pulse pressure values, but a poor CVH status
and severe edentulism were more frequent in those with
increased pulse pressure. Also, a history of stroke or ischemic
heart disease was more common among persons with an
increased pulse pressure (Table 4).
A total of 44 persons (7%) were positive on the ECQ.
Thirty-five of them also had increased values of pulse
pressure. Only nine of these 44 persons had grade II
(severe) suspected intermittent claudication, defined as a
positive response to question number 4 (Table 1). Per-
sons with a positive ECQ were older, more frequently
women, than those with a negative ECQ. There were
no differences in educational levels, alcohol intake, BMI,
total cholesterol blood levels, severe edentulism, or his-
tory of vascular events across both groups. However, mean
fasting glucose levels were higher and the CVH status
was more often poor among persons with a positive ECQ
(Table 5).
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positive (𝑛 = 44) negative (𝑛 = 621)
Age (mean ± SD) 59.5 ± 12.6 66.3 ± 11.9 59 ± 12.5 0.0001
Women, 𝑛 (%) 384 (58%) 32 (73%) 352 (57%) 0.054
Up to primary school, 𝑛 (%) 426 (64%) 30 (68%) 396 (64%) 0.67
Alcohol intake ≥50 g/day, 𝑛 (%) 114 (17%) 5 (11%) 109 (18%) 0.396
Current smokers, 𝑛 (%) 12 (2%) 1 (2.3%) 11 (1.8%) 0.809
Body mass index, kg/m2 (mean ± SD) 27 ± 5 27 ± 5 27 ± 5 ⋅ ⋅ ⋅
Fasting glucose, mg/dL (mean ± SD) 140 ± 86 173 ± 105 137 ± 84 0.007
Total cholesterol, mg/dL (mean ± SD) 199 ± 33 200 ± 30 199 ± 33 0.845
Poor CVH status, 𝑛 (%) 464 (70%) 40 (91%) 424 (68%) 0.003
Severe edentulism, 𝑛 (%) 192 (29%) 16 (36%) 176 (28%) 0.335
Stroke or ischemic heart disease, 𝑛 (%) 41 (6%) 4 (9%) 37 (6%) 0.610










(𝑛 = 451)‡ 𝑃 value
Age (mean ± SD) 59.5 ± 12.6 66.3 ± 11.9 68.1 ± 12 55.6 ± 10.9 0.0001
Women, 𝑛 (%) 384 (58%) 32 (73%) 108 (64%) 244 (54%) 0.015
Up to primary school, 𝑛 (%) 426 (64%) 30 (68%) 134 (79%) 262 (58%) 0.0001
Alcohol intake ≥50 g/day, 𝑛 (%) 114 (17%) 5 (11%) 19 (11%) 90 (20%) 0.02
Current smokers, 𝑛 (%) 12 (2%) 1 (2.3%) 2 (1.2%) 9 (2%) 0.767
Body mass index, kg/m2 (mean ± SD) 27 ± 5 27 ± 5 27 ± 5 27 ± 5 ⋅ ⋅ ⋅
Systolic BP, mmHg (mean ± SD) 138 ± 25 158 ± 26 164 ± 27 126 ± 13 0.0001
Diastolic BP, mmHg (mean ± SD) 77 ± 12 78 ± 13 79 ± 15 77 ± 10 0.159
BP ≥140/90mmHg, 𝑛 (%) 242 (36%) 32 (73%) 138 (81%) 72 (16%) 0.0001
Fasting glucose, mg/dL (mean ± SD) 140 ± 86 173 ± 105 148 ± 91 133 ± 81 0.004
Fasting glucose ≥126mg/dL, 𝑛 (%) 197 (30%) 21 (48%) 59 (35%) 117 (26%) 0.003
Total cholesterol, mg/dL (mean ± SD) 199 ± 33 200 ± 30 198 ± 32 199 ± 33 0.914
Poor CVH status, 𝑛 (%) 464 (70%) 40 (91%) 155 (91%) 269 (60%) 0.0001
Severe edentulism, 𝑛 (%) 192 (29%) 16 (36%) 72 (42%) 104 (23%) 0.0001
Stroke or ischemic heart disease, 𝑛 (%) 41 (6%) 4 (9%) 21 (12%) 16 (4%) 0.0002
∗Positive Edinburgh claudication questionnaire irrespective of pulse pressure levels; §increased pulse pressure levels and a negative Edinburgh claudication
questionnaire; ‡normal pulse pressure levels and a negative Edinburgh claudication questionnaire.
Table 6 summarizes the characteristics of enrolled per-
sons according to whether they were suspected or nonsus-
pected cases of PAD. There were no differences in demo-
graphics or in cardiovascular risk factors across categories
of suspected PAD (symptomatic or asymptomatic). In con-
trast, with the exception of BMI, diastolic BP, and total
cholesterol blood levels, persons with nonsuspected PAD
differed significantly from those with either symptomatic or
asymptomatic PAD.
4. Discussion
It has been estimated that more than 200 million individuals
worldwide are afflicted with PAD [4]. The disease has been
described as a pandemic sparing no nation [35]. The current
study confirms a high prevalence of suspected PAD in the
adult population of a rural village located in coastal Ecuador.
Forty-four persons (7%) had suspected symptomatic PAD
and 170 (26%) had suspected asymptomatic PAD.While these
numbers have to be confirmed during Phase II of this study,
they are consistent with the high stroke prevalence (31‰) and
with the high number of fatal ischemic heart disease cases
that we recently found in Atahualpa [22, 36]. Of note, these
findings support previous estimates that the incidence of car-
diovascular diseases is increasing in underserved populations
of Latin America [2]. Consistent with previous studies [37],
individuals with suspected PADwere more often women and
had more modifiable cardiovascular risk factors than those
without suspected PAD.
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Published data on PAD from Latin America are scarce. A
recent comprehensive review identified 12 population-based
studies conducted in low- and middle-income countries of
which only two came from urban centers in Latin America
and none were from rural areas [4]. In the Brazilian study
(1,008 subjects aged ≥30 years), the prevalence of PAD was
20% [38] while in the Mexican study (400 subjects aged ≥ 40
years) it was 10% [39]. In both studies, PAD was associated
with more cardiovascular risk factors; however, both studies
were cross-sectional and no data on the incidence of vascular
events was available. Our cohort study will fill a gap in the
literature by proving unbiased data on PAD prevalence, clin-
ical correlates, progression, and related vascular outcomes in
community-dwelling adults living in a rural South American
village. The methodology and operational definitions used
in this Atahualpa Project-ancillary study could be applied
in other population-based studies conducted in rural areas
of other middle- and low-income countries to help health
authorities to implement strategies directed to reduce the
burden of cardiovascular diseases in the region.
The rigorous methodology and comprehensive inclusion
of residents of an isolated community in this study will
provide a unique opportunity to estimate the prevalence of
PAD and its risk factors. However, we will use the ABI to
confirm the diagnosis and not physiologic methods of PAD
detection. Therefore, it is possible that the true prevalence
of PAD might be underestimated; this is a limitation of
the current study. Another potential limitation could be the
relatively small sample size, whichmay create some problems
in the multivariate adjusted model that will be used during
Phase II and Phase III of this study.
In summary, PAD appears to be highly prevalent in this
rural population in Ecuador confirming the global nature of
the PAD pandemic and its predilection for persons of both
sexes with modifiable cardiovascular risk factors in low- and
middle-income countries.
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